Hitomi Tomura

Title: Hitomi Tomura: Innovator in Antibody Development

Introduction

Hitomi Tomura is a prominent inventor based in Takasaki, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 3 patents, her work has the potential to impact therapeutic and diagnostic applications.

Latest Patents

One of her latest patents involves an anti-TIM-3 antibody. This invention discloses an anti-human TIM-3 antibody that exhibits high antibody-dependent cellular cytotoxicity (ADCC) activity. The patent details the screening of a monoclonal antibody or its fragment that binds to the amino acid sequence of the extracellular region of TIM-3 or its three-dimensional structure. Additionally, it includes a hybridoma that produces the antibody, a DNA encoding the antibody, and a vector comprising the DNA. The patent also outlines a method for producing the antibody or its fragment using the hybridoma or transformant, along with a therapeutic agent and a diagnostic agent that includes the antibody as an active ingredient.

Career Highlights

Hitomi Tomura has worked with notable institutions, including Kyushu University and Kyowa Hakko Kirin Co., Limited. Her experience in these organizations has allowed her to advance her research and contribute to the field of antibody development.

Collaborations

Some of her notable coworkers include Shin-ichiro Takayanagi and Tomonori Tawara. Their collaboration has likely fostered innovative ideas and advancements in their shared field of research.

Conclusion

Hitomi Tomura's work in developing anti-TIM-3 antibodies showcases her innovative spirit and dedication to advancing biotechnology. Her contributions are poised to make a significant impact in therapeutic and diagnostic applications.